Return to MD Anderson Cancer Center

Return to Department of Thoracic and Cardiovascular Surgery

What's New
Faculty & Staff
  Stephen Swisher, M.D.
    Curriculum Vitae
Education
Specific Diseases
Videos
Research
F.A.Q.
Glossary of Terms
Web Links
Thoracic Center
Contact Information

 

  

Curriculum Vitae - Stephen G. Swisher, M.D.

Academic and Professional Appointments:

2002- present, Director, Esophageal Cancer Program, Division of Surgery, Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

2001-present, Associate Professor of Surgery and Associate Surgeon, Division of Surgery, Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

1998-present, Faculty of Virology Program at the Graduate School of Biomedical Science, Research Investigator, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

1997-present, Mentor, Summer Research Program, Office of Academic Affairs, Research Investigator, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

1996-2001, Assistant Professor of Surgery and Assistant Surgeon, Division of Surgery, Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

1995-1996, Junior Faculty Associate, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

1993-1994, Clinical Instructor of General Surgery, Olive View, University of California at Los Angeles Medical Center, Los Angeles, California

Back to Top

Editorships and Editorial Board Memberships:

Editorial Boards

  • Molecular Cancer, 2001-present
  • Clinical Lung Cancer, 1998-present

Adhoc Reviews

  • Reviewer, Human Gene Therapy, 2002-present
  • Reviewer, Head and Neck, 2002-present
  • Reviewer, European Journal of Thoracic & Cardiovascular Surgery, 2001-present
  • Reviewer, American Journal of Cancer, 2001-present
  • Reviewer, Journal of Surgical Oncology, 2001-present
  • Reviewer, Lung Cancer, 2000-present
  • Reviewer, Cancer Research, 2000-present
  • Reviewer, Clinical Cancer Research, 2000-present
  • Reviewer, Irish Board of Grant Reviews, 1999
  • Reviewer, Annals of Thoracic Surgery, 1998-present
  • Reviewer, Cancer, 1998-present
  • Reviewer, Gene Therapy, 1998-present
  • Reviewer, Annals of Surgical Oncology, 1997-present

Back to Top

Honors and Awards:

  • The University of Texas Health Sciences Center, Houston, Resident Teaching Award, 2002
  • Burroughs Wellcome Clinical Scientist Award in Translational Research, MDACC nominee, 2000
  • Peruvian Society of Medical Oncology, Honorary Member, 1998
  • Golden Scalpel Chief Award, UCLA Medical Center Resident, 1993
  • Presidential Award (alternate), Society for Leukocyte Biology, 1989
  • Surgery Honors, UCSD Medical School, 1986
  • Lange Publications Award, UCSD Medical School, 1986
  • Department Distinctions (Biology/History), Stanford University, 1982
  • Fairclough Award (Classics), Stanford University, 1982
  • Phi Beta Kappa, Stanford University, 1982
  • Yale Book Award, Menlo School, 1977


Back to Top

Society Memberships and Offices Held:

  • General Thoracic Surgical Club, 2001-present
  • Southern Thoracic Surgical Association, 2000-present
  • American Association for Cancer Research, 2000-present
  • The Society of Thoracic Surgeons, 1998-present
  • American Society of Clinical Oncology, 1997-present
  • International Society for Diseases of the Esophagus, 1997-present
  • The University of Texas M.D. Anderson Associates, 1997-present
  • The American Board of Thoracic Surgery, 1997-present
  • Cooley Hands, 1996-present
  • Denton A. Cooley Cardiovascular Society, 1996-present
  • Society of Surgical Oncology, 1996-present
  • International Association for the Study of Lung Cancer, 1996-present
  • Texas Medical Association, 1994-present
  • Harris County Medical Society, 1994-present
  • Longmire Surgical Society, 1993-present
  • American College of Surgeons (Fellow), 1998-present
  • American Medical Association, 1986-present
  • Phi Beta Kappa Honor Society, 1982-present
  • Steering Committee (UCSD Student Government), 1982-1986
  • American Cancer Society, 1982-1986
  • American Medical Student Association, 1982-1986
  • Western Student Research Medical Committee, 1983-1986
  • Recruitment and Admissions Committee (UCSD), 1983-1986

Back to Top

Bibliography:

Published and accepted articles in refereed journals

Published and accepted invited journal articles

Published and accepted book chapters

Back to Top

Institutional Service Responsibilities and Other Duties:

Service or duties

  • UGI Tissue Committee, 2002-present
  • Faculty Achievement Awards Subcommittee, 2001-present
  • PRS Compensation and Fringe Benefits Committee, 1999-present
  • Division of Surgery Research Seminar Committee, 1998-present
  • GU Oncology Clinical Working Group, 1998-present
  • The W.M. Keck Center for Cancer Gene Therapy Vector Core Subcommittee, 1998-present
  • Secondary Peer Reviewer for Department of Thoracic and Cardiovascular Surgery, 1998-present
  • Medical Practice Subcommittee, 1997-present

Other

  • Bristol-Myers Lung Cancer Advisory Board, 1999-present
  • Ethicon Endo-Surgery Advisory Board, 1999-2001
  • Aventis Lung Cancer Advisory Board, 1999-2001
  • Alza Lung Cancer Advisory Board, 1998-2001

Back to Top

Formal Teaching Experience:

Back to Top

Invitations to National or International Conferences:

Back to Top

Seminar Invitations from Other Institutions:

  1. Blood Transfusion and Esophageal Cancer, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China, September, 1996.
  2. Multimodality Therapy of Resectable Non-Small Cell Lung Cancer, Seminar at Osaka University, Osaka, Japan, May, 1999.
  3. Use of Neoadjuvant Chemotherapy in Non-Small Cell Lung Cancer, Seminar at Tokushuma University, Tokushuma, Japan, May, 1999.
  4. Multidisciplinary Approach to Lung Cancer, Seminar at Fukuoka University, Fukuoka, Japan, May, 1999.
  5. Adenoviral p53 Treatment of Non-Small Cell Lung Cancer, Seminar at University of Berne, Berne, Switzerland, November, 2000.
  6. The Use of p53 Gene Therapy for Patients with Sold Tumors, Visiting Professor Seminar at Case Western Reserve University School of Medicine, Ireland Cancer Center, Cleveland, OH, August 2001.
  7. Adenoviral p53 Gene Therapy for Lung Cancer, Visiting Professor Seminar at Oregon Health Science University, Portland, OR, January 2002.

Back to Top

Other Activities:

  1. Induction of Apoptosis with Adenoviral Bax Recombinant, Introgen Therapeutics, Inc., Houston, TX, September, 1997.
  2. Multimodality Conference on Thoracic Malignancies, Orlando Telemed Conference, Houston, TX, December, 1997.
  3. Integration of Ad5CMB-p53 with Radiation Therapy in Multiple Tumor Tissue Types, Expert Panel Meeting, Philadelphia, PA, November, 1997.
  4. Potentially Resectable Non-Small Cell Lung Cancer: Is Surgery Enough? Oncology Teleconference, April, 1998.
  5. Panel Discussion, Advances in Clinical Research, Cancer in the 21st Century, Albert and Margaret Alkek Hospital, Houston, TX, November, 1998.
  6. Gene Therapy - P.I.K.N.I.C, The University of Texas MD Anderson Cancer Center, Houston, TX, March, 1999.
  7. Status of Neoadjuvant/Adjuvant Therapy for Resectable NSCLC, Webcast for Academy of Medicine of New Jersey (AMNJ), Princeton Junction, NJ, August, 1999.
  8. Adenoviral p53 Gene Therapy in Lung Cancer, MDACC Donors Symposium, Chicago, IL, December, 2000.
  9. Proposal of Randomized Phase III Esophageal Cancer Trial, Radiation Therapy Oncology Group (RTOG). Tampa, FL, February 2001.
  10. Proposal of Phase II Study of Esophageal Cancer, GI in Lung Cancer Study Group, Bethesda, Washington, March 2001.
  11. Ad-p53 Gene Transfer Strategies for Non-Small Cell Lung Cancer, 9th Annual Radiation Workshop Round Top. Round Top, TX, March 2001.
  12. Lung Cancer: Progress, Biology, and Clinical Implications (Virtual CME course), 2001 Annual American Society of Clinical Oncology Meeting, San Francisco, CA, May 2001.

Back to Top